Reviewer Board (845)

Members of the reviewer board are selected from all Cancers reviewers for regularly providing timely high quality reports on submitted manuscripts. Responsibilities of reviewers are available here.

Dr. Muriel Abbaci
1: Gustave Roussy, Plate-forme Imagerie et Cytométrie, UMS 23/3655, Université Paris-Saclay, Villejuif, France
2: Université Paris-Saclay, CEA, CNRS, Inserm, Laboratoire d'Imagerie Biomédicale Multimodale, Orsay, France
Interests: cancer; Fluorescence; near infrared imaging; indocyanine green; endomicroscopy; optical coherence tomography
Dr. Karim Alexandre Abid
Laboratory of catecholamines and peptides, Service of clinical pharmacology, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland
Interests: Metabolism of catecholamine in adrenal medulla and pheochromocytoma; Measurement of catecholamine and metabolites for diagnosis of neuroendocrine tumors; Optimization of radionucleide (MIBG and somatostatine analogues) uptake and binding in cancer cells
Dr. Abhinav Achreja
Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA
Interests: cancer metabolism; metabolic flux analysis; systems biology; Bioinformatics; machine learning; precision medicine; personalized medicine
Dr. Güliz Acker
Department of Neurosurgery and Cyberknife center, Charité Universitätsmedizin Berlin, Berlin, Germany
Interests: glioblastoma multiforme; angiogenesis; radiosurgery; radionecrosis; radiationbiology; PET; moyamoya; 3D imaging
Dr. Alfredo Addeo
Department of Oncology, University Hospital of Geneva, 1205 Genève, Switzerland
Interests: nsclc; sclc; biomarkers; tumour mutations burden; oncogene driver mutations; immunotherapy
Dr. Shailesh Advani
1. Department of Oncology, Georgetown University School of Medicine, Washington, DC, USA
2. Terasaki Institute of Biomedical Innovation, Los Angeles, CA, USA
Interests: Cancer epidemiology; cancer prevention; survivorship; health outcomes research
Dr. Francesco Agostini
Stem Cell Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy
Interests: mesenchymal stem cells; cancer; Drug delivery; good manufacturing practice; cell therapy; medium additive substitutes; microfluidic conditions
Dr. Mark Agostino
School of Pharmacy and Biomedical Sciences, Curtin Health Innovation Research Institute, and Curtin Institute for Computation, Curtin University, Perth WA 6102, Australia
Interests: computer-aided drug design; lead optimization; molecular recognition; structural biology; Molecular Docking; virtual screening; Molecular Dynamics; binding free energy calculations; wnt signalling; glycobiology
Dr. Fahim Ahmad
Molecular Imaging Program, National Cancer Institute/National Institutes of Health, Bethesda, MD 20892, USA
Interests: cancer; glioblastoma; prostate cancer; anticancer agents; metabolomics; hyperpolarized metabolic & amp; Molecular Imaging; radio carbon tracing; biomarker discovery; primary & 3d cell culture
Dr. Atif Ali Ahmed
University of Missouri-Kansas City, USA Children's Mercy Hospital 2401 Gillham Road. Kansas City, MO 64108 USA
Interests: Rhabdomyosarcoma, Neuroblastoma, Ewing's sarcoma
Dr. Shafiq U Ahmed
School of Medicine, Faculty of Health Sciences and Wellbeing, University of Sunderland, Sunderland SR1 3SD, UK
Interests: glioblastoma; cell cycle; Cell death; dna damage; Hypoxia
Dr. Abdulhameed Al-Ghabkari
Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, QC H3A 0G4, Canada
Interests: cancer; Cell Signaling; protein kinase; RTK; migration; invasion; Drug Discovery
Dr. Taslim Ahmed Al-Hilal
School of Pharmacy, The University of Texas at El Paso, TX 79902, USA
Interests: cancer angiogenesis; growth factor signaling; cancer fibrosis; cancer thrombosis; bioengineering cancer models; mirofluidics and cancer
Prof. Loredana Albonici
Department of Clinical Sciences and Translational Medicine, School of Medicine, University of Rome, “Tor Vergata”, Via Montpellier 1, 00133 Rome, Italy
Interests: analysis of molecular mechanisms associated with tumor growth and progression related to angiogenesis; Analysis of molecular mechanisms associated with polarized immune cells in tumor microenvironment
Dr. Elena Alexandrova
Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”, University of Salerno, 84081 Baronissi (SA), Italy
Interests: breast cancer; ovarian cancer; endocrine resistance; anti-cancer drugs; targeted therapy; Estrogen Receptor Modulators; cancer genomics; epigenetics
Dr. Brittany Allen-Petersen
Department of Molecular and Medical Genetics, Oregon Health and Sciences University, Portland, OR 97201, USA
Interests: pancreatic cancer; phosphatases; cancer cell signaling; cellular plasticity; PP2A, therapeutic response; 3D culture; mouse models of cancer
Dr. Pierpaolo Alongi
Unit of Nuclear Medicine, Fondazione Istituto G. Giglio, 90015 Cefalù, Italy
Interests: PET/CT; SPECT; prostate cancer; Molecular Imaging; neuroimaging
Dr. Sergio Alonso
Institut d'Investigació Germans Trias i Pujol (IGTP), Campus Can Ruti, 08916 Badalona, Spain
Interests: cancer epigenetics; cancer genetics; colorectal cancer; dna methylation; epigenomics; gastrointestinal cancer; Genomics; bioinformatics and computational biology
Dr. Veronica Alonso
Bone Physiophatology Laboratory, Department of Basic Medical Sciences, San Pablo CEU University, CEU Universities, Campus Monteprincipe, 28925 Alcorcón, Spain
Interests: Bone metastases; mindin; prostate cancer; pre metastatic niche; pth1r; bone signaling
Dr. Mohammad Alzrigat
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
Interests: cancer biology; gene regulation; myc; epigenetics; chromatin modifiers; polycomb; epigenetic therapy
Back to TopTop